EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model

Synergism of BARF1 with Ras Induces Malignant Transformation in Primary Primate Epithelial Cells and Human Nasopharyngeal Epithelial Cells

(2015) Richeng Jiang et al.   NEOPLASIA

Effect of DNAzymes targeting Akt1 on cell proliferation and apoptosis in nasopharyngeal carcinoma

(2010) Lifang Yang et al.   CANCER BIOLOGY & THERAPY

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

(2010) W.-Y. Wang et al.   CLINICAL CANCER RESEARCH

Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion

(2009) Cheng-Hsun Ho et al.   CARCINOGENESIS

Epstein–Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance

(2009) Jian-Hong Lu et al.   LABORATORY INVESTIGATION

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells

(2009) HaiDan Liu et al.   Molecular Cancer

Specific repression of mutant K-RAS by 10–23 DNAzyme: Sensitizing cancer cell to anti-cancer therapies

(2008) Szu-Hsien Yu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

EBV LMP2A affects LMP1-mediated NF- B signaling and survival of lymphoma cells by regulating TRAF2 expression

(2008) I. Guasparri et al.   BLOOD

DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma

(2008) Zhong-Xin Lu et al.   CANCER LETTERS

Reconstitution of Nasopharyngeal Carcinoma-Type EBV Infection Induces Tumorigenicity

(2008) E. Seto et al.   CANCER RESEARCH

EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells

(2008) Xuechi Lin et al.   INTERNATIONAL JOURNAL OF CANCER

Latent Membrane Protein 1 of Epstein-Barr Virus Activates the hTERT Promoter and Enhances Telomerase Activity in B Lymphocytes

(2008) L. Terrin et al.   JOURNAL OF VIROLOGY

DNAzyme technology and cancer therapy: cleave and let die

(2008) C. R. Dass et al.   MOLECULAR CANCER THERAPEUTICS

Epstein-Barr Nuclear Antigen 1 Contributes to Nasopharyngeal Carcinoma through Disruption of PML Nuclear Bodies

(2008) Nirojini Sivachandran et al.   PLoS Pathogens